VAERS reports by lot

Pfizer COVID-19 lot NJ6625: VAERS reports

21 VAERS reports list lot NJ6625 as a Pfizer COVID-19 vaccine, received between 2026-02-09 and 2026-05-27. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
10%
Marked serious
0
With a death outcome
4
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular3427%
Neurological2016%
General / Systemic (non-local)1814%
Injection-site / Local reaction1613%
Gastrointestinal119%
Dermatological (non-injection-site)119%
Respiratory65%
Allergic / Anaphylactic32%
Musculoskeletal32%
Thrombotic / Hematological22%
Psychiatric / Neuropsychiatric22%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
California7
Washington2
Minnesota1
Colorado1
Virginia1
South Carolina1
North Carolina1
Tennessee1
Mississippi1
Arizona1
Texas1
Georgia1

Reports by month received

MonthReportsBar
2026-021
2026-034
2026-046
2026-0510

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Pfizer COVID-19 lots (A–Z): NA4457 · NA4459 · NE4289 · PAA156051 · PAA165969 · PAA173696

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.